Back to News
Market Impact: 0.35
Madrigal (MDGL) Q3 Earnings and Revenues Beat Estimates
Source: zacks.com
Corporate EarningsHealthcare & BiotechCompany Fundamentals
Madrigal reported quarterly earnings of $1.83 per share, beating the Zacks Consensus Estimate of a $1.09-per-share loss. Earnings improved from a $5.08-per-share loss in the year-ago quarter.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
moderately positive
Sentiment Score
0.45
Ticker Sentiment
MDGL0.70
More News
- Madrigal Pharma stock soars 10% on profit beat, strong Rezdiffra sales
- What Madrigal Pharmaceuticals (MDGL) Said on Its Q3 Earnings Call
- Binance co-CEO Richard Teng says hackers used fake job interviews, AI tool to steal $6.3 billion in crypto 108511116
- AMD stock jumps 7% on earnings as data center revenue nearly doubles
- Marvell Technology could plunge on latest multibillion-dollar acquisition
- Disney Plans Thousands of Layoffs Companywide